Resonant Link Medical, an innovative medical technology company redefining wireless power and data transfer for implantable devices, announced the appointment of Omari V. Bouknight as Chief Executive Officer (CEO). Bouknight brings more than two decades of experience commercializing novel medical technologies globally.
“Omari is the ideal leader to scale Resonant Link Medical’s vision and impact—expanding the reach of implantable medical devices, accelerating innovation for industry partners, and ultimately transforming patient outcomes,” said Jeff Chu, Managing Partner at Features Capital and Resonant Link Medical Board Member. “His deep expertise in advancing medical technologies, combined with a proven track record of commercializing them across diverse applications, makes him uniquely suited to lead Resonant Link Medical into its next phase of growth. We are excited to leverage Omari’s clinical, commercial, and product leadership to shape the future of implantable devices through Resonant Link Medical’s enabling wireless power technology.”
Also Read: NAMSA Completes Acquisition of WuXi AppTec US Medical Device Testing Business
Prior to joining Resonant Link Medical, Bouknight served as US Divisional Vice President of Commercial for Abbott’s Structural Heart Business, where he drove significant growth while leading five medical device product franchises. He previously served as President and Chief Commercial Officer for CardioFocus and Vice President of Sales and Marketing at Cardiac Dimensions. Bouknight also served as Business Unit Director at Thoratec Corporation, where he led the highly successful launch of the HeartMate II Left Ventricular Assist System. He began his medical technology career working for Guidant Corporation in strategy and clinical roles. Bouknight received his Master of Business Administration from Harvard Business School and his Bachelor’s degrees from Michigan State University.
Bouknight will lead efforts to broaden Resonant Link Medical’s commercial reach and innovation pipeline, building on its success helping medical device companies deliver more effective and convenient treatments for people living with health conditions such as chronic pain, epilepsy, depression, sleep apnea, and heart failure. Resonant Link Medical‘s technology platform enables fast, safe, and convenient wireless power transfer, delivering up to ten times faster charging than conventional wireless transfer methods. The platform’s capabilities are inspiring smaller, smarter, and longer-lasting devices that allow patients to live their lives untethered.
SOURCE: PRWeb